ATIM-35. VXM01 PHASE I STUDY IN PATIENTS WITH PROGRESSIVE GLIOBLASTOMA – FINAL RESULTS
Wolfgang Wick(Hertie Institute for Clinical Brain Research), Michael Platten(National Center for Tumor Diseases), Sébastien Wieckowski(Centre National de la Recherche Scientifique), Christel Herold‐Mende, Heinz Lubenau(Vaximm (Germany)), Philipp Kickingereder(Heidelberg University), Dennis Riehl(European Molecular Biology Organization), Antje Wick(Heidelberg University), Andreas von Deimling(Heidelberg University), Felix Sahm(German Cancer Research Center), Philipp Beckhove(University Hospital Regensburg), Christine Jungk, Friedrich Hubertus Schmitz Winnenthal(Klinikum Aschaffenburg), Anne-Valérie Keller(Vaximm (Germany)), Andreas Unterberg(Humboldt-Universität zu Berlin), Lilli Podola(Vaximm (Germany)), Martin Bendszus(Heidelberg University)
Cited by 5
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke
|Stroke|2013|1.7k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
|The Lancet Oncology|2017|1.1k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k